FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2912177757> ?p ?o ?g. }

• W2912177757 endingPage "615" @default.
• W2912177757 startingPage "604" @default.
• W2912177757 abstract "Abstract Introduction In Scandinavian countries, programs for fertility preservation are offered free of charge at tertiary‐care university hospitals to all patients facing treatments with risk of subsequent sterility. In this prospective study we aimed to investigate trends in female patients’ choices after counseling and fertility preservation outcomes during follow up in relation to benign vs malignant indications. Material and methods Data on 1254 females including 1076 adults and 178 girls who received fertility preservation counseling for either oncologic (n = 852) or benign indications (n = 402) at Karolinska University Hospital, Stockholm, between 1 October 1998 and 1 December 2018 were analyzed. As appropriate, t tests and chi‐square tests were used to compare groups. Logistic regression was used to compare outcomes among groups depending on indications. Results Adult women generally elected to undergo oocyte retrieval after controlled ovarian stimulation for cryopreservation of embryos or oocytes (n = 538, 73%), whereas a minor proportion opted for cryopreservation of ovarian tissue retrieved through laparoscopy (n = 221, 27%). More than half of the women with a partner chose either not to fertilize their oocytes aiming at cryopreservation of oocytes or to share obtained oocytes attempting both cryopreservation of oocytes and cryopreservation of embryos. All pre‐pubertal (n = 48) and 73% of post‐pubertal girls (n = 66) elected cryopreservation of ovarian tissue. In recent years, an increasing number of teenagers have opted for controlled ovarian stimulation aiming at cryopreservation of oocytes, either before (n = 24, 17%) or after completion of cancer treatment (n = 15, 10%). During follow up, 27% of the women returned for a new reproductive counseling, additional fertility preservation or to attempt pregnancy. Utilization rates among individuals who were alive and of childbearing age by December 2018 indicated 29%, 8% and 5% for embryos, oocytes and ovarian tissue with live birth rates of 54%, 46% and 7%, respectively. Women with benign indications were significantly younger than women with previous malignant indications at the time of attempting pregnancy. Although the pregnancy rates were similar among both groups, the live birth rate was significantly higher in women with benign vs previous malignant indications (47% vs 21%, P = .002). Conclusions Trends in fertility preservation choices have changed over time. Women with previous malignancy had lower live birth rates than women with benign fertility preservation indications." @default.
• W2912177757 created "2019-02-21" @default.
• W2912177757 creator A5001208847 @default.
• W2912177757 creator A5007336377 @default.
• W2912177757 creator A5016797607 @default.
• W2912177757 creator A5017637420 @default.
• W2912177757 creator A5030997598 @default.
• W2912177757 creator A5031911841 @default.
• W2912177757 creator A5036073672 @default.
• W2912177757 creator A5036536744 @default.
• W2912177757 creator A5036574350 @default.
• W2912177757 creator A5048783452 @default.
• W2912177757 creator A5050129368 @default.
• W2912177757 date "2019-03-18" @default.
• W2912177757 modified "2023-10-17" @default.
• W2912177757 title "A prospective study of women and girls undergoing fertility preservation due to oncologic and non‐oncologic indications in Sweden–Trends in patients’ choices and benefit of the chosen methods after long‐term follow up" @default.
• W2912177757 cites W1967153348 @default.
• W2912177757 cites W1990468943 @default.
• W2912177757 cites W2013359667 @default.
• W2912177757 cites W2018337042 @default.
• W2912177757 cites W2022055550 @default.
• W2912177757 cites W2044652864 @default.
• W2912177757 cites W2051551422 @default.
• W2912177757 cites W2054836722 @default.
• W2912177757 cites W2066546957 @default.
• W2912177757 cites W2094369979 @default.
• W2912177757 cites W2104676776 @default.
• W2912177757 cites W2109241620 @default.
• W2912177757 cites W2131661369 @default.
• W2912177757 cites W2150267695 @default.
• W2912177757 cites W2176253027 @default.
• W2912177757 cites W2237181971 @default.
• W2912177757 cites W2410504707 @default.
• W2912177757 cites W2604348698 @default.
• W2912177757 cites W2607361286 @default.
• W2912177757 cites W2616395902 @default.
• W2912177757 cites W2626932218 @default.
• W2912177757 cites W2737269187 @default.
• W2912177757 cites W2742930962 @default.
• W2912177757 cites W2767028423 @default.
• W2912177757 cites W2782307525 @default.
• W2912177757 cites W2782985751 @default.
• W2912177757 cites W2786090367 @default.
• W2912177757 cites W2787556478 @default.
• W2912177757 cites W2795588819 @default.
• W2912177757 cites W2801247381 @default.
• W2912177757 cites W2808218105 @default.
• W2912177757 cites W2808953783 @default.
• W2912177757 cites W2902500338 @default.
• W2912177757 cites W2917037609 @default.
• W2912177757 cites W4231837847 @default.
• W2912177757 cites W4239386978 @default.
• W2912177757 doi "https://doi.org/10.1111/aogs.13559" @default.
• W2912177757 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30723910" @default.
• W2912177757 hasPublicationYear "2019" @default.
• W2912177757 type Work @default.
• W2912177757 sameAs 2912177757 @default.
• W2912177757 citedByCount "55" @default.
• W2912177757 countsByYear W29121777572019 @default.
• W2912177757 countsByYear W29121777572020 @default.
• W2912177757 countsByYear W29121777572021 @default.
• W2912177757 countsByYear W29121777572022 @default.
• W2912177757 countsByYear W29121777572023 @default.
• W2912177757 crossrefType "journal-article" @default.
• W2912177757 hasAuthorship W2912177757A5001208847 @default.
• W2912177757 hasAuthorship W2912177757A5007336377 @default.
• W2912177757 hasAuthorship W2912177757A5016797607 @default.
• W2912177757 hasAuthorship W2912177757A5017637420 @default.
• W2912177757 hasAuthorship W2912177757A5030997598 @default.
• W2912177757 hasAuthorship W2912177757A5031911841 @default.
• W2912177757 hasAuthorship W2912177757A5036073672 @default.
• W2912177757 hasAuthorship W2912177757A5036536744 @default.
• W2912177757 hasAuthorship W2912177757A5036574350 @default.
• W2912177757 hasAuthorship W2912177757A5048783452 @default.
• W2912177757 hasAuthorship W2912177757A5050129368 @default.
• W2912177757 hasBestOaLocation W29121777571 @default.
• W2912177757 hasConcept C126322002 @default.
• W2912177757 hasConcept C141071460 @default.
• W2912177757 hasConcept C151956035 @default.
• W2912177757 hasConcept C179933525 @default.
• W2912177757 hasConcept C18597862 @default.
• W2912177757 hasConcept C188816634 @default.
• W2912177757 hasConcept C196843134 @default.
• W2912177757 hasConcept C205545832 @default.
• W2912177757 hasConcept C2776687438 @default.
• W2912177757 hasConcept C2777904497 @default.
• W2912177757 hasConcept C2778459216 @default.
• W2912177757 hasConcept C2908647359 @default.
• W2912177757 hasConcept C29456083 @default.
• W2912177757 hasConcept C518429986 @default.
• W2912177757 hasConcept C54355233 @default.
• W2912177757 hasConcept C59843425 @default.
• W2912177757 hasConcept C71924100 @default.
• W2912177757 hasConcept C86803240 @default.
• W2912177757 hasConcept C95444343 @default.
• W2912177757 hasConcept C99454951 @default.
• W2912177757 hasConceptScore W2912177757C126322002 @default.
• W2912177757 hasConceptScore W2912177757C141071460 @default.

• next